Medication treatment for Parkinson's disease in China — get 3 personalized clinic matches

Medication treatment for Parkinson's disease in China typically costs from $900 to $2,300. The total expense depends on whether patients choose generic or brand-name drugs and the clinical setting. Patients save approximately 64% compared to the US, where similar care costs $4,400 on average. Core costs usually cover outpatient prescriptions, initial diagnostic consultations, and standard neurological follow-ups.

• Drug sourcing: Centrally procured foundational drugs like levodopa/benserazide cost significantly less than imported brand-name equivalents.
• Hospital tiering: Treatment at Class A level III facilities in Beijing or Tianjin typically commands a premium.
• Private healthcare: International clinics in major hubs like Beijing and Tianjin offer faster access at higher rates.
• Insurance subsidies: Local insurance schemes can cover 50% to 75% of outpatient prescription costs for residents.

Bookimed Expert Insight: China offers high-value neurological care by integrating Western medicine with Traditional Chinese Medicine. Leading centers like Yanda International Hospital, which is Joint Commission International (JCI) accredited, serve over 2 million patients annually. Expert neurologists, including those with Harvard postdoctoral training, provide advanced protocols at these institutions. Patients can find exceptional value in Tianjin and Beijing, where tertiary hospitals offer hybrid operating rooms and deep brain stimulation technologies.